PeptideDB

HGH

Aprovado pela FDA

Human Growth Hormone | Somatropin

Human Growth Hormone (HGH/Somatropin) is a 191-amino acid polypeptide hormone FDA-approved for pediatric and adult growth hormone deficiency, HIV-associated wasting, and other conditions.

Dados moleculares e de pesquisa

Peso molecular
22,124 Da
Meia-vida
3-4 hours (SC), 20-30 minutes (IV)
Alvos primários
gh-direct, igf1
Vias (pesquisa)
injectable
Armazenamento
Lyophilized: Room temperature. Reconstituted: 2-8°C, use within 14-28 days

Overview

Human Growth Hormone (HGH/Somatropin) is a 191-amino acid polypeptide hormone FDA-approved for pediatric and adult growth hormone deficiency, HIV-associated wasting, and other conditions. It provides both direct and indirect (IGF-1 mediated) anabolic effects.

Mechanism of action

Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation. Indirect effects via IGF-1 promote growth and anabolism. Half-life ~3 hours subcutaneously.

Key research findings

  • Improved body composition (increased lean mass, decreased fat)
  • Enhanced bone mineral density
  • Improved lipid profile
  • Increased exercise capacity
  • Better quality of life and mood
  • Skin, hair, and nail improvements
  • Enhanced recovery and healing

Research applications

Growth Hormone Deficiency

  • Pediatric GH Deficiency — FDA-approved for idiopathic and organic causes, Turner syndrome, Prader-Willi syndrome, SGA, Noonan syndrome, SHOX deficiency.
  • Adult GH Deficiency — FDA-approved for childhood-onset or adult-onset causes (pituitary tumors, surgery, radiation, trauma).
  • HIV-Associated Wasting — FDA-approved to increase lean body mass and body weight in cachexia.

Body Composition

  • Fat Loss — Significant fat loss especially abdominal/visceral fat over 1-3 months.
  • Lean Mass — Increased muscle mass and improved body composition.
  • Recovery Enhancement — Enhanced exercise recovery and tissue healing.

Anti-Aging

  • Skin and Hair Quality — Improved skin elasticity, texture, and hair/nail growth.
  • Energy and Well-being — Improved energy, sleep, and quality of life.

FAQ de HGH

Will HGH unmask thyroid problems?+

Yes. HGH unmasks central hypothyroidism in 36-47% of users by increasing T4-to-T3 conversion. Get baseline thyroid labs (TSH, free T4, free T3) before starting and recheck at 6-8 weeks. Many users need T4 supplementation while on HGH.

How much carpal tunnel syndrome should I expect from HGH?+

Carpal tunnel symptoms are common (10-30% of users) and typically mild to moderate. They usually resolve with dose reduction. Symptoms typically peak at 2-4 weeks and improve as your body adapts. Starting low and titrating up reduces risk.

Does HGH require continuous use or can I cycle it?+

HGH effects are dose-dependent and reversible. Most users cycle 3-6 months on, 1-2 months off to maintain sensitivity and allow recovery of natural GH production. Continuous use is possible but may increase side effect risk over time.

Can HGH cause diabetes?+

HGH decreases insulin sensitivity, potentially unmasking pre-diabetes or causing diabetes in susceptible individuals. Monitor fasting glucose and HbA1c regularly. Those with family history of diabetes should proceed cautiously and may need metformin support.

References

  1. [1]Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15,809 GH-Treated PatientsJournal of Clinical Endocrinology & Metabolism
  2. [2]Efficacy and Safety of Growth Hormone Treatment in Adults with Growth Hormone Deficiency: A Systematic Review of Studies on MorbidityClinical Endocrinology
  3. [3]Cardiovascular Risk in Growth Hormone Deficiency: Beneficial Effects of Growth Hormone Replacement TherapyEndocrine
  4. [4]Unmasking of Central Hypothyroidism Following Growth Hormone Replacement in Adult Hypopituitary PatientsClinical Endocrinology
  5. [5]A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real LifeJournal of Endocrinological Investigation
  6. [6]Developments in the Management of Growth Hormone Deficiency: Clinical Utility of SomapacitanDrug Design, Development and Therapy

Peptídeos relacionados